- Home
- About
- Team
- Today's Market
- Premium
- Research it
- Outlook
- Portfolio
- Mobile
- Trust Equitymaster
- Help
- Free Reports
MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- ORTIN LABS
ORTIN LABS Share Price 
(ORTI)
Here is the latest stock price and chart of Ortin Labs . For a sector overview, read our pharmaceuticals sector report.
| Live BSE Quotes | Oct 19, 2018 02:05:00 PM | ||
|---|---|---|---|
| Price (Rs)16.85 | Open (Rs) 16.70 | High (Rs) 17.00 | Low (Rs) 16.50 |
| % Change-1.46 | Volume 8,105 | Value (Rs) 136,569 | 52-Week H/L 34.40 / 13.25 |
| Live NSE Quotes | Oct 19, 2018 1:52:11 PM | ||
|---|---|---|---|
| Price (Rs)16.70 | Open (Rs) 17.00 | High (Rs) 17.00 | Low (Rs) 16.25 |
| % Change-1.18 | Volume 5,705 | Value (Rs) 94,247 | 52-Week H/L 34.40 / 13.20 |
| BSE Sensex | CNX Nifty |
- Charts
-
PERIOD - Advanced Charts new
- Charts by TradingView
ORTIN LABS Share Price Today:
ORTIN LABS share price is down 1.5% to Rs 16.9 on the BSE. On the NSE, the ORTIN LABS share price is down 1.2% to Rs 16.7. The total volume of shares traded is 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index is trading down by 1.0%. And the benchmark S&P BSE SENSEX is at 34,180.3 (down 1.7%).
Over the last 30 days, the ORTIN LABS share price is down 22.2%. And over the last one year, ORTIN LABS share price is up 0.6%.
|
| |
Today's Market
Sensex Down 420 Points; IT Stocks Tank(12:30 pm)
After opening the day in red, share markets in India have traded on a negative note and are presently trading below the dotted line.
Related Views On News
Aster DM Healthcare (IPO)
Feb 10, 2018Should you subscribe to the IPO of Aster DM Healthcare Ltd?
Shalby Ltd. (IPO)
Dec 2, 2017Should you subscribe to the IPO of Shalby Ltd?
The Power of 5 Minutes (The 5 Minute Wrapup)
Jun 16, 2017Here's what you can expect from The 5 Minute Wrapup in the coming months and years.
Eris Lifesciences Limited (IPO)
Jun 15, 2017Exposure to high margin specialty products offers promising growth prospects.
Laurus Labs Ltd (IPO)
Dec 6, 2016Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.
More Views on NewsMost Popular
This Market Crash could be the Biggest Wealth Creating Opportunity Since 2008(Profit Hunter)
Oct 8, 2018While widespread fear is the friend of a value investor, serving up bargain purchases; personal fear is an investor's biggest enemy.
My Top 3 Tips to Navigate the Market Crash(The 5 Minute Wrapup)
Oct 8, 2018Steep corrections are never easy to handle. It's hard to watch the value of your shares drop so much. But you can take steps to make the most of it.
IPO Market Feels the Heat of the Market Crash(Sector Info)
Oct 12, 2018The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.
Even If IL&FS Group Brought This Correction, this is Right Time to Buy & Sit Tight!(Chart Of The Day)
Oct 12, 2018Even if IL&FS is the culprit, it may turn out to be a hero if you buy right and sit tight.
ICICI Prudential Manufacture In India Fund: A Make In India Prodigy, Should You Invest?(Outside View)
Oct 8, 2018PersonalFN briefly explains if you should be investing in the NFO: ICICI Prudenetial Manufacture in India Fund.
MoreTRACK ORTIN LABS
- Track your investment in ORTIN LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
OTHER USEFUL LINKS
MARKET STATS
|
| |
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.